Showing results (101-110 of 182) with videos related to
Sort By:
Pageof 19
Endocrine Connections|March 14, 2019
NETest liquid biopsy is diagnostic of small intestine and pancreatic neuroendocrine tumors and correlates with imagingAnna Malczewska, Magdalena Witkowska, Karolina Makulik, et al.European Journal of Nuclear Medicine and Molecular Imaging|June 27, 2015
Feasibility and utility of re-treatment with (177)Lu-DOTATATE in GEP-NENs relapsed after treatment with (90)Y-DOTATOCStefano Severi, Maddalena Sansovini, Annarita Ianniello, et al.Pituitary|April 27, 2007
Treatment of a pituitary metastasis from a neuroendocrine tumour: case report and literature reviewUmberto Goglia, Diego Ferone, Marilena Sidoti, et al.The Prostate|April 4, 2024
Development of a multigenomic liquid biopsy (PROSTest) for prostate cancer in whole bloodIrvin M Modlin, Mark Kidd, Ignat A Drozdov, et al.European Journal of Nuclear Medicine and Molecular Imaging|March 26, 2009
Peptide receptor radionuclide therapy with (90)Y-DOTATOC in recurrent meningiomaMirco Bartolomei, Lisa Bodei, Concetta De Cicco, et al.Journal of Neuro-Oncology|June 1, 2005
Intratumoral delivery of mitoxantrone in association with 90-Y radioimmunotherapy (RIT) in recurrent glioblastomaAmerigo Boiardi, Mirco Bartolomei, Antonio Silvani, et al.European Journal of Nuclear Medicine and Molecular Imaging|October 31, 2018
Biodistribution and radiation dose estimates for <sup>68</sup>Ga-DOTA-JR11 in patients with metastatic neuroendocrine tumorsSimone Krebs, Neeta Pandit-Taskar, Diane Reidy, et al.The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|November 19, 2015
Therapeutic schemes in 177Lu and 90Y-PRRT: radiobiological considerationsAnna Sarnelli, Francesco Guerriero, Francesca Botta, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 28, 2010
Small-animal PET/CT for monitoring the development and response to chemotherapy of thymic lymphoma in Trp53-/- miceMartin A Walter, Isabel J Hildebrandt, Katrin Hacke, et al.Cancer Treatment Reviews|December 7, 2010
Biological targeted therapies in patients with advanced enteropancreatic neuroendocrine carcinomasNicola Fazio, Saverio Cinieri, Katia Lorizzo, et al.Pageof 19